Design, Synthesis, Molecular Docking, and Biological Evaluation of Tanshinone IIA Derivatives as Antibreast Cancer...

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Cancer Biology

Background:

• Tanshinone IIA is a natural compound with known biological activities.
• Exploring derivatives of Tanshinone IIA can lead to enhanced therapeutic properties.
• Amino introduction is a strategy to modify Tanshinone IIA's structure and function.

Purpose of the Study:

• To synthesize novel N-substituted Tanshinone IIA derivatives.
• To evaluate the anti-proliferative and antitumor activities of these derivatives.
• To investigate the mechanism of action of the most potent derivative.

Main Methods:

• Synthesis of 18 N-substituted Tanshinone IIA derivatives.
• In vitro anti-proliferative assays against various cancer cell lines.
• Apoptosis induction studies, cell cycle analysis, and metastasis inhibition assays.
• Molecular docking to predict binding interactions.

Main Results:

• Compound TA-16 demonstrated potent cytotoxic effects against cervical, colon, liver, and breast cancer cells (IC50 = 1.25 µM against MCF-7).
• TA-16 induced apoptosis via the mitochondrial pathway and arrested the cell cycle at the G0/G1 phase.
• TA-16 inhibited metastasis by reducing MMP-9 and MMP-2 expression.
• TA-16 showed selectivity towards cancer cells over normal breast epithelial cells (selectivity index of 4.95).

Conclusions:

• Compound TA-16 is a highly potent anticancer agent with significant anti-proliferative and anti-metastasis properties.
• TA-16's mechanism involves apoptosis induction and cell cycle arrest.
• TA-16 shows potential as a therapeutic agent for breast cancer due to its efficacy and selectivity.